Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies
- DOI
- 10.1001/jamahealthforum.2023.2260
- Published
- 2023-08-04
- Container
- JAMA Health Forum
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamahealthforum.2023.2260,
title = {Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies},
author = {Zachary A. Sexton and Juliana R. Perl and Henry R. Saul and Artem A. Trotsyuk and Jan B. Pietzsch and Sandra Waugh Ruggles and Margaret C. Nikolov and Kevin A. Schulman and Josh Makower},
year = {2023},
journal = {JAMA Health Forum},
doi = {10.1001/jamahealthforum.2023.2260},
url = {https://doi.org/10.1001/jamahealthforum.2023.2260}
}RIS
TY - JOUR TI - Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies AU - Zachary A. Sexton AU - Juliana R. Perl AU - Henry R. Saul AU - Artem A. Trotsyuk AU - Jan B. Pietzsch AU - Sandra Waugh Ruggles AU - Margaret C. Nikolov AU - Kevin A. Schulman AU - Josh Makower PY - 2023 JO - JAMA Health Forum DO - 10.1001/jamahealthforum.2023.2260 UR - https://doi.org/10.1001/jamahealthforum.2023.2260 ER -
APA
Sexton, Z. A., Perl, J. R., Saul, H. R., Trotsyuk, A. A., Pietzsch, J. B., Ruggles, S. W., Nikolov, M. C., Schulman, K. A., & Makower, J. (2023). Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2023.2260
Source records
- crossref · retrieved 2026-09-27T11:07:44.317Z